Afatinib as Cancer Therapy for Exocrine Pancreatic Tumours (ACCEPT)

Clinical Trial ID NCT01728818

PubWeight™ 5.08‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01728818

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies. Ther Adv Med Oncol 2015 1.00
2 Current and future systemic treatment options in metastatic pancreatic cancer. J Gastrointest Oncol 2014 0.95
3 Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future. J Hematol Oncol 2015 0.91
4 FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer. World J Gastroenterol 2016 0.82
5 State of the art biological therapies in pancreatic cancer. World J Gastrointest Oncol 2016 0.78
6 Pancreatic cancer from bench to bedside: molecular pathways and treatment options. Ann Transl Med 2016 0.75
Next 100